Physicians
Find out why adding Cervista® HPV HR to your cervical cancer screening enables better patient management. Cervista HPV HR is the only FDA approved test that:
- Does not cross react with common low risk HPV types so that patients at higher risk can be identified.
- Requires lower specimen volume to reduce patient callbacks due to quantity not sufficient (QNS).
- Utilizes an internal control that verifies adequate specimen is present to render a valid result.
The Cervista HPV HR test is approved for use with the ThinPrep® Pap test. With a single sample, you get reliable results you can count on.
